Drug Trial Radar · NCT00705341
MethaCholine Bronchoprovocation Study (MeCIS)
Last checked: Nov 20, 2026Latest source record: Feb 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
219
Actual
Start
Jan 2009
Primary completion
Feb 2010
Study completion Feb 2010
Sponsor
- Lead sponsor
- Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Washington University School of Medicine; St. Louis University; Long Island Jewish Medical Center; North Shore University Hospital; Baylor College of Medicine; University of Vermont; Nemours Children's Clinic; University of Florida; Indiana University; Ohio State University; NYU Langone Health; University of Missouri-Columbia; Northwestern University; Louisiana State University Health Sciences Center in New Orleans; University of Miami; University of South Florida; University of California, San Diego; National Jewish Health; Duke University
- First posted
- Jun 26, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 12 years, up to 69 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this research is to evaluate the methacholine challenge test as an accurate indicator of asthma in patients receiving treatment for asthma. Phase 1 on the study compares methacholine challenge test results from asthma patients to those from people who do not have asthma. In phase 2, test results for people with asthma on low dose inhaled corticosteroid will be compared to results on high dose inhaled corticosteroids. Both males and females with stable asthma (asthma participants) and without asthma (controls) enrolled. Participants will be between 12 and 69 years of age.
Conditions
- Asthma
Interventions
fluticasoneDrug
Inhaled corticosteroid approved for treatment of asthma
Primary outcomes
What the sponsor says the trial is designed to measure.
- Methacholine Challenge Test Result for Phase 2Time frame: weeks 0, 4
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
University of California at San Diego
San Diego, California
The Nemours Children's Clinic
Jacksonville, Florida
University of Miami/Univestiy of South Florida
Miami, Florida
Northwestern University Memorial Hospital
Chicago, Illinois
Indiana University
Indianapolis, Indiana
Louisianna State University
New Orleans, Louisiana
University of Missouri-Kansas City
Kansas City, Missouri
Washington University School of Medicine
St Louis, Missouri
Long Island Jewish Medical Center
New Hyde Park, New York
New York Consortium/Columbia University
New York, New York
New York Medical College
Valhalla, New York
Ohio State University
Columbus, Ohio
Vermont Lung Center at the University of Vermont
Burlington, Vermont
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.